Natural Alternatives International Inc cash flow statement
In fiscal 2026, Natural Alternatives International Inc's operations generated −$8.9m of cash; it spent $3.7m on capital projects, leaving free cash flow of −$12.6m. It returned $89,000 through buybacks.
Cash flow statement
| Fiscal year | 2011Jun 2011 | 2012Jun 2012 | 2013Jun 2013 | 2014Jun 2014 | 2015Jun 2015 | 2016Jun 2016 | 2017Jun 2017 | 2018Jun 2018 | 2019Jun 2019 | 2020Jun 2020 | 2021Jun 2021 | 2022Jun 2022 | 2023Jun 2023 | 2024Jun 2024 | 2025Jun 2025 | 2026Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 9 | 2 | 4 | 5 | 3 | 9 | 14 | 2 | 7 | 4 | 21 | 12 | 7 | −1 | 6 | −9 |
| Depreciation and amortisation | 3 | 3 | 3 | 3 | 2 | 2 | 2 | 3 | 3 | 4 | 4 | 4 | 4 | 5 | 5 | 5 |
| Stock-based pay | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 |
| Capital spending | 2 | 2 | 2 | 3 | 2 | 10 | 5 | 4 | 5 | 5 | 5 | 26 | 14 | 3 | 4 | 4 |
| Free cash flow | 7 | −1 | 3 | 3 | 1 | −1 | 9 | −2 | 1 | −1 | 16 | −15 | −7 | −5 | 2 | −13 |
| Free cash flow after stock pay | 7 | −1 | 3 | 2 | 1 | −2 | 8 | −4 | −0 | −3 | 14 | −16 | −8 | −6 | 1 | −13 |
| Share buybacks | 0 | 0 | 1 | 0 | 2 | 1 | 1 | 1 | 1 | 4 | 4 | 6 | 2 | 0 | 0 | 0 |
| Shares issued | 0 | — | 0 | — | — | — | — | — | 0 | — | — | — | — | — | — | — |
| Quarter | 2025 Q1Sept 2024 | 2025 Q2Dec 2024 | 2025 Q3Mar 2025 | 2025 Q4Jun 2025 | 2026 Q1Sept 2025 | 2026 Q2Dec 2025 | 2026 Q3Mar 2026 | 2026 Q4Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −3,443 | 37 | 5,993 | 3,345 | −4,023 | −6,330 | 2,503 | −1,066 |
| Depreciation and amortisation | 1,127 | 1,134 | 1,139 | 1,160 | 1,166 | 1,166 | 1,194 | 1,183 |
| Stock-based pay | 276 | 277 | 245 | 179 | 177 | 178 | 140 | 108 |
| Capital spending | 301 | 1,056 | 802 | 1,455 | 1,030 | 934 | 1,100 | 637 |
| Free cash flow | −3,744 | −1,019 | 5,191 | 1,890 | −5,053 | −7,264 | 1,403 | −1,703 |
| Free cash flow after stock pay | −4,020 | −1,296 | 4,946 | 1,711 | −5,230 | −7,442 | 1,263 | −1,811 |
Compare with peers
- Zevra Therapeutics, Inc. cash flow
- Heron Therapeutics, Inc. cash flow
- Niagen Bioscience, Inc. cash flow
- Amarin Corp plc\uk cash flow
- Cronos Group Inc. cash flow
Head to head: NAII vs ZVRAHRTX vs NAIINAGE vs NAII
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies